Nampt/visfatin/PBEF affects expression of myogenic regulatory factors and is regulated by interleukin-6 in chicken skeletal muscle cells

Comparative Biochemistry and Physiology - A Molecular and Integrative Physiology

Volumn 159, Issue 4, 2011, Pages 413-421

  Krzysik Walker, Susan M ^a   Hadley, Jill A ^a   Pesall, Jane E ^b   McFarland, Douglas C ^b   Vasilatos Younken, Regina ^a   Ramachandran, Ramesh ^a  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

^b SOUTH DAKOTA STATE UNIVERSITY   (United States)

Author keywords

Glucose uptake; Mrf4; Myf5; MyoD

Indexed keywords

COMPLEMENTARY DNA; INTERLEUKIN 6; MESSENGER RNA; METENKEPHALIN[6 ARGININE 7 PHENYLALANINE]; MYOD PROTEIN; MYOGENIC FACTOR; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL TYPE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE OVEREXPRESSION; GLUCOSE TRANSPORT; MUSCLE CELL; MUSCLE DEVELOPMENT; MYOBLAST; NONHUMAN; SKELETAL MUSCLE;

GALLUS GALLUS; MAMMALIA;

EID: 79957604613     PISSN: 10956433     EISSN: 15314332     Source Type: Journal    
DOI: 10.1016/j.cbpa.2011.04.007     Document Type: Article

References (64)

1. Baeza-Raja B., Munoz-Canoves P. p38 MAPK-induced nuclear factor-kappaB activity is required for skeletal muscle differentiation: role of interleukin-6. Mol Biol Cell 2004, 15:2013-2026.
2. Bartoccioni E., Michaelis D., Hohlfeld R. Constitutive and cytokine-induced production of interleukin-6 by human myoblasts. Immunol Lett 1994, 42:135-138.
3. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976, 72:248-254.
4. Chen H., Xia T., Zhou L., Chen X., Gan L., Yao W., Peng Y., Yang Z. Gene organization, alternate splicing and expression pattern of porcine visfatin gene. Domest Anim Endocrinol 2007, 32:235-245.
5. Chen M.P., Chung F.M., Chang D.M., Tsai J.C., Huang H.F., Shin S.J., Lee Y.J. Elevated plasma level of visfatin/pre-B cell colony-enhancing factor in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab 2006, 91:295-299.
6. Costford S.R., Bajpeyi S., Pasarica M., Albarado D.C., Thomas S.C., Xie H., Church T., Jubrias S.A., Conley K.E., Smith S.R. Skeletal muscle NAMPT is induced by exercise in humans. Am J Physiol Endocrinol Metab. 2010, 298:E117-E126.
7. De Rossi M., Bernasconi P., Baggi F., de Waal Malefyt R., Mantegazza R. Cytokines and chemokines are both expressed by human myoblasts: possible relevance for the immune pathogenesis of muscle inflammation. Int Immunol 2000, 12:1329-1335.
8. Dietrich L.S., Fuller L., Yero I.L., Martinez L. Nicotinamide mononucleotide pyrophosphorylase activity in animal tissues. J Biol Chem 1966, 241:188-191.
9. Dogru T., Sonmez A., Tasci I., Bozoglu E., Yilmaz M.I., Genc H., Erdem G., Gok M., Bingol N., Kilic S., Ozgurtas T., Bingol S. Plasma visfatin levels in patients with newly diagnosed and untreated type 2 diabetes mellitus and impaired glucose tolerance. Diabetes Res Clin Pract 2006, 76:24-29.
10. Duclos M.J., Chevalier B., Le Marchand-Brustel Y., Tanti J.F., Goddard C., Simon J. Insulin-like growth factor-I-stimulated glucose transport in myotubes derived from chicken muscle satellite cells. J Endocrinol 1993, 137:465-472.
11. Erten Y., Ebinc F.A., Ebinc H., Pasaoglu H., Demirtas C., Tacoy G., Koc E., Derici U., Reis K.A., Bali M., Arinsoy T., Sindel S. The relationship of visfatin levels to inflammatory cytokines and left ventricular hypertrophy in hemodialysis and continuous ambulatory peritoneal dialysis patients. Ren Fail 2008, 30:617-623.
12. Febbraio M.A., Pedersen B.K. Muscle-derived interleukin-6: mechanisms for activation and possible biological roles. FASEB J 2002, 16:1335-1347.
13. Fukuhara A., Matsuda M., Nishizawa M., Segawa K., Tanaka M., Kishimoto K., Matsuki Y., Murakami M., Ichisaka T., Murakami H., Watanabe E., Takagi T., Akiyoshi M., Ohtsubo T., Kihara S., Yamashita S., Makishima M., Funahashi T., Yamanaka S., Hiramatsu R., Matsuzawa Y., Shimomura I. Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science 2005, 307:426-430.
14. Fukuhara A., Matsuda M., Nishizawa M., Segawa K., Tanaka M., Kishimoto K., Matsuki Y., Murakami M., Ichisaka T., Murakami H., Watanabe E., Takagi T., Akiyoshi M., Ohtsubo T., Kihara S., Yamashita S., Makishima M., Funahashi T., Yamanaka S., Hiramatsu R., Matsuzawa Y., Shimomura I. Retraction. Science 2007, 318:565.
15. Fulco M., Cen Y., Zhao P., Hoffman E.P., McBurney M.W., Sauve A.A., Sartorelli V. Glucose restriction inhibits skeletal myoblast differentiation by activating SIRT1 through AMPK-mediated regulation of Nampt. Dev Cell 2008, 14:661-673.
16. Fulco M., Schiltz R.L., Iezzi S., King M.T., Zhao P., Kashiwaya Y., Hoffman E., Veech R.L., Sartorelli V. Sir2 regulates skeletal muscle differentiation as a potential sensor of the redox state. Mol Cell 2003, 12:51-62.
17. Harasim E., Chabowski A., Gorski J. Lack of downstream insulin-mimetic effects of visfatin/eNAMPT on glucose and fatty acid metabolism in skeletal muscles. Acta Physiol (Oxf). 2011, 202:21-28. 10.1111/j.1748-1716.2011.02254.x.
18. Hawke T.J., Garry D.J. Myogenic satellite cells: physiology to molecular biology. J Appl Physiol 2001, 91:534-551.
19. Hernvann A., Cynober L., Aussel C., Agneray J., Ekindjian O. Sensitivity of cultured fibroblasts to human, bovine and porcine insulins. Cell Biol Int Rep 1987, 11:591-598.
20. Jia S.H., Li Y., Parodo J., Kapus A., Fan L., Rotstein O.D., Marshall J.C. Pre-B cell colony-enhancing factor inhibits neutrophil apoptosis in experimental inflammation and clinical sepsis. J Clin Invest 2004, 113:1318-1327.
21. Jonsdottir I.H., Schjerling P., Ostrowski K., Asp S., Richter E.A., Pedersen B.K. Muscle contractions induce interleukin-6 mRNA production in rat skeletal muscles. J Physiol 2000, 528:157-163.
22. Kim J.Y., Bae Y.H., Bae M.K., Kim S.R., Park H.J., Wee H.J., Bae S.K. Visfatin through STAT3 activation enhances IL-6 expression that promotes endothelial angiogenesis. Biochim Biophys Acta 2009, 1793:1759-1767.
23. Kloting N., Kloting I. Visfatin: gene expression in isolated adipocytes and sequence analysis in obese WOKW rats compared with lean control rats. Biochem Biophys Res Commun 2005, 332:1070-1072.
24. Kralisch S., Klein J., Lossner U., Bluher M., Paschke R., Stumvoll M., Fasshauer M. Interleukin-6 is a negative regulator of visfatin gene expression in 3T3-L1 adipocytes. Am J Physiol Endocrinol Metab 2005, 289:586-590.
25. Krzysik-Walker S.M., Ocon-Grove O.M., Maddineni S.R., Hendricks G.L., Ramachandran R. Is visfatin an adipokine or myokine? Evidence for greater visfatin expression in skeletal muscle than visceral fat in chickens. Endocrinology 2008, 149:1543-1550.
26. Li L., Yang G., Li Q., Tang Y., Yang M., Yang H., Li K. Changes and relations of circulating visfatin, apelin, and resistin levels in normal, impaired glucose tolerance, and type 2 diabetic subjects. Exp Clin Endocrinol Diabetes 2006, 114:544-548.
27. Li X., McFarland D.C., Velleman S.G. Effect of Smad3-mediated transforming growth factor-beta1 signaling on satellite cell proliferation and differentiation in chickens. Poult Sci 2008, 87:1823-1833.
28. Li X., McFarland D.C., Velleman S.G. Extracellular matrix proteoglycan decorin-mediated myogenic satellite cell responsiveness to transforming growth factor-beta1 during cell proliferation and differentiation Decorin and transforming growth factor-beta1 in satellite cells. Domest Anim Endocrinol 2008, 35:263-273.
29. Liu S.W., Qiao S.B., Yuan J.S., Liu D.Q. Visfatin stimulates production of monocyte chemotactic protein-1 and interleukin-6 in human vein umbilical endothelial cells. Horm Metab Res 2009, 41:281-286.
30. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001, 25:402-408.
31. Magni G., Amici A., Emanuelli M., Raffaelli N., Ruggieri S. Enzymology of NAD+ synthesis. Adv Enzymol Relat Areas Mol Biol 1999, 73:135-182. xi.
32. Mauro A. Satellite cell of skeletal muscle fibers. J Biophys Biochem Cytol 1961, 9:493-495.
33. McFarland D.C., Gilkerson K.K., Pesall J.E., Ferrin N.H., Wellenreiter R.H. In vitro characteristics of myogenic satellite cells derived from the pectoralis major and biceps femoris muscles of the chicken. Cytobios 1997, 91:45-52.
34. McFarland D.C., Pesall J.E., Gilkerson K.K., Ferrin N.H., Ye W.V., Swenning T.A. Comparison of protein metabolism and glucose uptake in turkey (Melegaris gallopavo) satellite cells and embryonic myoblasts in vitro. Comp Biochem Physiol A 1994, 107:301-306.
35. McFarland D.C., Velleman S.G., Pesall J.E., Liu C. The role of myostatin in chicken (Gallus domesticus) myogenic satellite cell proliferation and differentiation. Gen Comp Endocrinol 2007, 151:351-357.
36. McGlothlin J.R., Gao L., Lavoie T., Simon B.A., Easley R.B., Ma S.F., Rumala B.B., Garcia J.G., Ye S.Q. Molecular cloning and characterization of canine pre-B-cell colony-enhancing factor. Biochem Genet 2005, 43:127-141.
37. McKay B.R., De Lisio M., Johnston A.P., O'Reilly C.E., Phillips S.M., Tarnopolsky M.A., Parise G. Association of interleukin-6 signalling with the muscle stem cell response following muscle-lengthening contractions in humans. PLoS One 2009, 4:e6027.
38. Moschen A.R., Kaser A., Enrich B., Mosheimer B., Theurl M., Niederegger H., Tilg H. Visfatin, an adipocytokine with proinflammatory and immunomodulating properties. J Immunol 2007, 178:1748-1758.
39. Moss F.P., Leblond C.P. Satellite cells as the source of nuclei in muscles of growing rats. Anat Rec 1971, 170:421-435.
40. Nowell M.A., Richards P.J., Fielding C.A., Ognjanovic S., Topley N., Williams A.S., Bryant-Greenwood G., Jones S.A. Regulation of pre-B cell colony-enhancing factor by STAT-3-dependent interleukin-6 trans-signaling: implications in the pathogenesis of rheumatoid arthritis. Arthritis Rheum 2006, 54:2084-2095.
41. Ocon-Grove O.M., Krzysik-Walker S.M., Maddineni S.R., Hendricks G.L., Ramachandran R. NAMPT (visfatin) in the chicken testis: influence of sexual maturation on cellular localization, plasma levels and gene and protein expression. Reproduction 2010, 139:217-226.
42. Ognjanovic S., Bao S., Yamamoto S.Y., Garibay-Tupas J., Samal B., Bryant-Greenwood G.D. Genomic organization of the gene coding for human pre-B-cell colony enhancing factor and expression in human fetal membranes. J Mol Endocrinol 2001, 26:107-117.
43. Oki K., Yamane K., Kamei N., Nojima H., Kohno N. Circulating visfatin level is correlated with inflammation, but not with insulin resistance. Clin Endocrinol (Oxf) 2007, 67:796-800.
44. Palin M.F., Labrecque B., Beaudry D., Mayhue M., Bordignon V., Murphy B.D. Visfatin expression is not associated with adipose tissue abundance in the porcine model. Domest Anim Endocrinol 2008, 35:58-73.
45. Palmer R.M., Thompson M.G., Knott R.M., Campbell G.P., Thom A., Morrison K.S. Insulin and insulin-like growth factor-I responsiveness and signalling mechanisms in C2C12 satellite cells: effect of differentiation and fusion. Biochim Biophys Acta 1997, 1355:167-176.
46. Pesall J.E., McFarland D.C., McMurtry J.P., Clapper J.A., Francis G.L., Gilkerson K.K. The effect of insulin-like growth factor analogs on turkey satellite cell and embryonic myoblast proliferation. Poult Sci 2001, 80:944-948.
47. Revollo J.R., Grimm A.A., Imai S. The NAD biosynthesis pathway mediated by nicotinamide phosphoribosyltransferase regulates Sir2 activity in mammalian cells. J Biol Chem 2004, 279:50754-50763.
48. Revollo J.R., Korner A., Mills K.F., Satoh A., Wang T., Garten A., Dasgupta B., Sasaki Y., Wolberger C., Townsend R.R., Milbrandt J., Kiess W., Imai S. Nampt/PBEF/Visfatin regulates insulin secretion in beta cells as a systemic NAD biosynthetic enzyme. Cell Metab 2007, 6:363-375.
49. Rongvaux A., Shea R.J., Mulks M.H., Gigot D., Urbain J., Leo O., Andris F. Pre-B-cell colony-enhancing factor, whose expression is up-regulated in activated lymphocytes, is a nicotinamide phosphoribosyltransferase, a cytosolic enzyme involved in NAD biosynthesis. Eur J Immunol 2002, 32:3225-3234.
50. Rudnicki M.A., Braun T., Hinuma S., Jaenisch R. Inactivation of MyoD in mice leads to up-regulation of the myogenic HLH gene Myf-5 and results in apparently normal muscle development. Cell 1992, 71:383-390.
51. Sabourin L.A., Rudnicki M.A. The molecular regulation of myogenesis. Clin Genet 2000, 57:16-25.
52. Samal B., Sun Y., Stearns G., Xie C., Suggs S., McNiece I. Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor. Mol Cell Biol 1994, 14:1431-1437.
53. Sartorelli V., Caretti G. Mechanisms underlying the transcriptional regulation of skeletal myogenesis. Curr Opin Genet Dev 2005, 15:528-535.
54. Seo J.A., Jang E.S., Kim B.G., Ryu O.H., Kim H.Y., Lee K.W., Kim S.G., Choi K.M., Baik S.H., Choi D.S., Kim N.H. Plasma visfatin levels are positively associated with circulating interleukin-6 in apparently healthy Korean women. Diabetes Res Clin Pract 2008, 79:108-111.
55. Serrano A.L., Baeza-Raja B., Perdiguero E., Jardi M., Munoz-Canoves P. Interleukin-6 is an essential regulator of satellite cell-mediated skeletal muscle hypertrophy. Cell Metab 2008, 7:33-44.
56. Song H.K., Lee M.H., Kim B.K., Park Y.G., Ko G.J., Kang Y.S., Han J.Y., Han S.Y., Han K.H., Kim H.K., Cha D.R. Visfatin: a new player in mesangial cell physiology and diabetic nephropathy. Am J Physiol Renal Physiol 2008, 295:F1485-F1494.
57. Tanaka M., Nozaki M., Fukuhara A., Segawa K., Aoki N., Matsuda M., Komuro R., Shimomura I. Visfatin is released from 3T3-L1 adipocytes via a non-classical pathway. Biochem Biophys Res Commun 2007, 359:194-201.
58. Tang H., Cheung W.M., Ip F.C., Ip N.Y. Identification and characterization of differentially expressed genes in denervated muscle. Mol Cell Neurosci 2000, 16:127-140.
59. van der Veer E., Nong Z., O'Neil C., Urquhart B., Freeman D., Pickering J.G. Pre-B-cell colony-enhancing factor regulates NAD+-dependent protein deacetylase activity and promotes vascular smooth muscle cell maturation. Circ Res 2005, 97:25-34.
60. Wanecq E., Prevot D., Carpene C. Lack of direct insulin-like action of visfatin/Nampt/PBEF1 in human adipocytes. J Physiol Biochem 2009, 65:351-359.
61. Wang P., Xu T.Y., Guan Y.F., Su D.F., Fan G.R., Miao C.Y. Perivascular adipose tissue-derived visfatin is a vascular smooth muscle cell growth factor: role of nicotinamide mononucleotide. Cardiovasc Res 2009, 81:370-380.
62. Wang T., Zhang X., Bheda P., Revollo J.R., Imai S., Wolberger C. Structure of Nampt/PBEF/visfatin, a mammalian NAD+ biosynthetic enzyme. Nat Struct Mol Biol 2006, 13:661-662.
63. Xie H., Tang S.Y., Luo X.H., Huang J., Cui R.R., Yuan L.Q., Zhou H.D., Wu X.P., Liao E.Y. Insulin-like effects of visfatin on human osteoblasts. Calcif Tissue Int 2007, 80:201-210.
64. Yablonka-Reuveni Z., Day K., Vine A., Shefer G. Defining the transcriptional signature of skeletal muscle stem cells. J Anim Sci 2008, 86:E207-E216.